What is Efalex used for?

Efalex is indicated for Breastfeeding (mother), Pregnancy, function.

What development phase is Efalex in?

Efalex is FDA-approved (marketed).

What are the side effects of Efalex?

Common side effects include Skin ailments, Gastrointestinal complaints, Glucose abnormalities, Visual problems.

What is the generic name of Efalex?

DOCONEXENT is the generic (nonproprietary) name of Efalex.

Last reviewed 2026-04-20 · How we verify

Efalex (DOCONEXENT)

FDA-approved active Small molecule Quality 33/100

At a glance

Generic name	DOCONEXENT
Drug class	Vitamin C [EPC]
Target	Free fatty acid receptor 1
Modality	Small molecule
Therapeutic area	Metabolic
Phase	FDA-approved

Approved indications

Breastfeeding (mother)
Pregnancy, function

Boxed warnings

WARNING: Accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under 6. Keep this product out of reach of children. In case of accidental overdose, call a doctor or poison control center immediately.

Common side effects

Skin ailments
Gastrointestinal complaints
Glucose abnormalities
Visual problems

Key clinical trials

The ORIGIN Trial (Outcome Reduction With Initial Glargine Intervention) (PHASE3)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Efalex CI brief — competitive landscape report
Efalex updates RSS · CI watch RSS